Testing a CAR T cell treatment for adults with cancer that spread to the brain
Original title: IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people, mostly to check if it is safe.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This early study tests an immune cell treatment for cancer that has spread to the brain.
Who this trial is for. This study tests a treatment made from a patient's own immune cells, which are changed on purpose. It is for adults whose cancer spread to the brain, whether the brain tumors are new or came back or grew after treatment.
Where it stands. This study has not reported any results yet. It is first checking if the treatment is safe. It is also checking if the treatment can be made and given to patients.
What this means, and what it doesn't
What it could mean: If you or someone you care for has cancer that spread to the brain, you could ask your care team about this study. They can help you think about whether a trial makes sense for you. The trial team decides who can join.
What it doesn't mean: This is a test, not a proven treatment. Being in a trial does not promise that it will help you. This early study is mostly about safety, and it is not a cure.
Source: ClinicalTrials.gov, September 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.